Small BAX agonists can induce conformational variations by blocking phosphorylation sites to facilitate BAX insertion into mitochondrial membranes and form BAX oligomers, which finally leads to the release of cytochrome c and apoptosis in several types of cancers [28]. Here, CYCS is linked to cancer.